Navigation Links
Omega-3 Fatty Acids May Help Heart Patients With Stents
Date:5/27/2011

By Kathleen Doheny
HealthDay Reporter

THURSDAY, May 26 (HealthDay News) -- Combining omega-3 fatty acids with blood-thinning drugs may reduce the risk of heart attacks in patients who've had stents placed in their coronary arteries, a new European study suggests.

While other research suggests that foods rich in omega-3s, including fatty fish such as salmon, help reduce the risk of heart problems in those with existing coronary artery disease, the new study is thought to be the first to look at the effect of the omega-3s on those treated with blood-thinning medications after stent placement.

In people with heart disease, a stent is a small tube placed in a coronary artery to keep it open and to allow the normal flow of blood and oxygen to the heart. But if a blood clot forms at the stent site, it can block blood flow and result in life-threatening problems such as a heart attack.

"Our results demonstrated improved clot properties and decreased thrombin [a clot promoter] formation after treatment with the fish oil capsules," wrote Dr. Grzegorz Gajos of John Paul II Hospital in Krakow, Poland, in the report.

Gajos and colleagues studied 54 patients, on average about 63 years old. They all had their clogged arteries opened by a catheter procedure. They then had stents inserted to keep the vessels open.

All were on the standard medical therapy used in these patients, including a daily dose of aspirin and an anti-platelet drug, clopidogrel (Plavix), for four weeks after the stent was installed.

Twenty-four patients were randomly assigned to receive a placebo pill daily and 30 patients received 1,000 milligrams of omega-3s (EPA and DHA) in pill form daily. The study was a double-blind, placebo-controlled trial -- meaning that neither the patients nor the researchers knew who was getting the omega-3s and who was getting the placebo (or sham treatment).

The researchers found that those who took the omega-3 fatty acids had improved clot properties and decreased clot formation after the treatment compared to the placebo group. The clots that formed in those on the fish oil pills, for example, were easier to disrupt.

The patients taking omega-3s not only produced less of the clot-promoting thrombin, their clots had larger pores and so were easier to break up. Clot destruction time in those patients was also 14.3 percent shorter than in the patients taking placebo pills.

Because there were not differences in other clotting features between the groups, the investigators felt that the finding indicated that the changes were due to the fish oil.

The researchers concluded that giving omega-3 fatty acids to patients who are stable after stent placement could improve outcomes, although they did not track outcomes for the patients in this study. Fish oil is not a replacement for the blood-thinner drugs or other treatments, they explained, but simply an adjunct (added) treatment.

However, the study authors pointed out that they could not extend the findings to other groups, such as those who are healthy, those with a high risk of coronary artery disease, or those not on the blood-thinning drugs. They are planning a larger study that will go on indefinitely, they added.

The study is published in the May 26 issue of Arteriosclerosis, Thrombosis and Vascular Biology: Journal of the American Heart Association.

The study is "trying to figure out why we might want to believe that omega-3 fatty acids have some benefit in this," said Dr. Kirk Garratt, clinical director of interventional cardiovascular research at the Lenox Hill Heart and Vascular Institute of New York, who was not involved in the study.

For the last 15 to 20 years, Garratt said, the benefits of fish oil have been debated. What the new study shows -- in a relatively small number of people -- is that if fish oil supplements are added to the usual medicine and medical care, "[scientists] find the scale has been tilted toward tearing down the clots rather than building up clots," he explained.

The study does not clarify exactly how the omega-3 fatty acids are affecting the blood clots, Garratt added, noting that the body is constantly making blood clots and that "there are forces that want to make clots and forces that want to tear them down." It is known, he said, that oxidative stress tilts the body toward formation of clots and makes it hard to tear them down. That would point to the antioxidant properties of fish oil getting the credit, he concluded.

The researchers found that giving the omega-3 fatty acids did not take away the body's inherent ability to make clots, he said, which is important to preserve.

If the antioxidants are responsible for affecting the blood clotting process, Garratt said, it could be they are revving up the body's ability to destroy clots.

What is not known, he said, is whether the findings mean that fish oil might help prevent heart attacks in these patients.

However, Garratt sees no reason to withhold fish oil from patients. "Fish oils have had more of a positive track record than negative track record," he said. High-potency fish oil affects blood fats favorably, he said, especially the triglycerides.

More information

To learn more about omega-3 fatty acids and the heart, visit the American Heart Association.

SOURCES: Kirk Garratt, M.D., M.Sc., clinical director of interventional cardiovascular research, Lenox Hill Heart and Vascular Institute of New York; May 26, 2011, Arteriosclerosis, Thrombosis and Vascular Biology: Journal of the American Heart Association


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Heart-Healthy Omega-3s Not Healthy for Prostate: Study
2. Vegans elevated heart risk requires omega-3s and B12
3. Vegans elevated heart risk requires omega-3s and B12
4. Certain Formulations of Omega-3s Might Help With Depression
5. Can Omega-3 Foods Prevent Eye Disease in Seniors?
6. Omega-3 Supplements Wont Fight Irregular Heartbeat
7. Low-Dose Omega-3 Fatty Acids Dont Protect Heart Patients
8. Salmon baby food? Babies need omega-3s and a taste for fish, scientist says
9. Omega-3 Cookie Company Recognized as Finalist for Prestigious Business Award
10. Omega-3 May Reduce Endometriosis Risk
11. Twinlab Launches New Omega-3 Powder in Single-Serving Stick Packs for Busy Parents and Their Kids
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Omega-3 Fatty Acids May Help Heart Patients With Stents
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Research ... World Market for Companion Diagnostic Tests" report to their ... Market for Companion Diagnostics The World Market ... and personalized medicine diagnostics. Market analysis in the report includes ... Test Market (In Vitro Diagnostic Kits) by Region (N. America, ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced today ... its e-clinical software solution of choice.  This latest ... possible value to their clients by offering a ... preferred relationship establishes nowEDC as the EDC platform ... MedSource,s full-service clients.  "nowEDC has long been a ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
Breaking Medicine Technology: